Terms: = Skin cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
90 results:
1. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
2. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
Guo D; Jurek R; Beaumont KA; Sharp DS; Tan SY; Mariana A; Failes TW; Grootveld AK; Bhattacharyya ND; Phan TG; Arndt GM; Jain R; Weninger W; Tikoo S
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2303978120. PubMed ID: 37963252
[TBL] [Abstract] [Full Text] [Related]
3. Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells.
Guo X; Fan A; Qi X; Liu D; Huang J; Lin W
Bioorg Chem; 2023 Dec; 141():106873. PubMed ID: 37734192
[TBL] [Abstract] [Full Text] [Related]
4. Intensified Adjuvant treatment for High-Risk Resected Cutaneous Angiosarcoma of the Head and Neck.
El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
[TBL] [Abstract] [Full Text] [Related]
5. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
6. Preventive Effect of Pharmaceutical Phytochemicals Targeting the src Family of Protein Tyrosine Kinases and Aryl Hydrocarbon Receptor on Environmental Stress-Induced skin Disease.
Paik SJ; Kim DJ; Jung SK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983027
[TBL] [Abstract] [Full Text] [Related]
7. Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome.
de Jesus AA; Chen G; Yang D; Brdicka T; Ruth NM; Bennin D; Cebecauerova D; Malcova H; Freeman H; Martin N; Svojgr K; Passo MH; Bhuyan F; Alehashemi S; Rastegar AT; Uss K; Kardava L; Marrero B; Duric I; Omoyinmi E; Peldova P; Lee CR; Kleiner DE; Hadigan CM; Hewitt SM; Pittaluga S; Carmona-Rivera C; Calvo KR; Shah N; Balascakova M; Fink DL; Kotalova R; Parackova Z; Peterkova L; Kuzilkova D; Campr V; Sramkova L; Biancotto A; Brooks SR; Manes C; Meffre E; Harper RL; Kuehn H; Kaplan MJ; Brogan P; Rosenzweig SD; Merchant M; Deng Z; Huttenlocher A; Moir SL; Kuhns DB; Boehm M; Skvarova Kramarzova K; Goldbach-Mansky R
Nat Commun; 2023 Mar; 14(1):1502. PubMed ID: 36932076
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic targets and signaling mechanisms of dasatinib activity against radiation skin ulcer.
Su W; Chen X; Zhang W; Li D; Chen X; Yu D
Front Public Health; 2022; 10():1031038. PubMed ID: 36530656
[TBL] [Abstract] [Full Text] [Related]
9. The AhR-src axis as a therapeutic vulnerability in BRAFi-resistant melanoma.
Paris A; Tardif N; Baietti FM; Berra C; Leclair HM; Leucci E; Galibert MD; Corre S
EMBO Mol Med; 2022 Dec; 14(12):e15677. PubMed ID: 36305167
[TBL] [Abstract] [Full Text] [Related]
10. CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.
Reigstad A; Herdlevær CF; Rigg E; Hoang T; Bjørnstad OV; Aasen SN; Preis J; Haan C; Sundstrøm T; Thorsen F
PLoS One; 2022; 17(9):e0273711. PubMed ID: 36084109
[TBL] [Abstract] [Full Text] [Related]
11. Nectin cell adhesion molecule 4 regulates angiogenesis through src signaling and serves as a novel therapeutic target in angiosarcoma.
Tanaka Y; Murata M; Tanegashima K; Oda Y; Ito T
Sci Rep; 2022 Mar; 12(1):4031. PubMed ID: 35256687
[TBL] [Abstract] [Full Text] [Related]
12. Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells.
Misek SA; Newbury PA; Chekalin E; Paithankar S; Doseff AI; Chen B; Gallo KA; Neubig RR
Mol Pharmacol; 2022 Jan; 101(1):1-12. PubMed ID: 34732527
[TBL] [Abstract] [Full Text] [Related]
13. Protein tyrosine phosphatase 1B(PTP1B) promotes melanoma cells progression through src activation.
Wang Q; Pan Y; Zhao L; Qi F; Liu J
Bioengineered; 2021 Dec; 12(1):8396-8406. PubMed ID: 34606417
[TBL] [Abstract] [Full Text] [Related]
14. Early-onset pulmonary and cutaneous vasculitis driven by constitutively active src-family kinase HCK.
Kanderova V; Svobodova T; Borna S; Fejtkova M; Martinu V; Paderova J; Svaton M; Kralova J; Fronkova E; Klocperk A; Pruhova S; Lee-Kirsch MA; Hornofova L; Koblizek M; Novak P; Zimmermannova O; Parackova Z; Sediva A; Kalina T; Janda A; Kayserova J; Dvorakova M; Macek M; Pohunek P; Sedlacek P; Poh A; Ernst M; Brdicka T; Hrusak O; Lebl J
J Allergy Clin Immunol; 2022 Apr; 149(4):1464-1472.e3. PubMed ID: 34536415
[TBL] [Abstract] [Full Text] [Related]
15. Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.
Berköz M; Özkan-Yılmaz F; Özlüer-Hunt A; Krośniak M; Türkmen Ö; Korkmaz D; Keskin S
Pharmacol Rep; 2021 Apr; 73(2):650-663. PubMed ID: 33609273
[TBL] [Abstract] [Full Text] [Related]
16. Kinome profiling analysis identified src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma.
Jimura N; Fujii K; Qiao Z; Tsuchiya R; Yoshimatsu Y; Kondo T; Kanekura T
J Dermatol Sci; 2021 Mar; 101(3):194-201. PubMed ID: 33531202
[TBL] [Abstract] [Full Text] [Related]
17. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
18. Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during skin Carcinogenesis.
Ramovs V; Krotenberg Garcia A; Kreft M; Sonnenberg A
J Invest Dermatol; 2021 Apr; 141(4):732-741.e6. PubMed ID: 32805217
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2.
Ma WL; Chou CH; Chen JP; Kuo SH
Dermatol Ther; 2020 Nov; 33(6):e14035. PubMed ID: 32683791
[TBL] [Abstract] [Full Text] [Related]
20. Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors.
Sibaud V; Beylot-Barry M; Protin C; Vigarios E; Recher C; Ysebaert L
Am J Clin Dermatol; 2020 Dec; 21(6):799-812. PubMed ID: 32613545
[TBL] [Abstract] [Full Text] [Related]
[Next]
